HDAC inhibitors as pharmacological treatment for Duchenne muscular dystrophy: a discovery journey from bench to patients: (Trends in Molecular Medicine, 30:3 p:278-294, 2024)

Trends Mol Med. 2024 Apr 19:S1471-4914(24)00084-4. doi: 10.1016/j.molmed.2024.03.012. Online ahead of print.NO ABSTRACTPMID:38643051 | DOI:10.1016/j.molmed.2024.03.012

Source: Trends in Molecular Medicine - April 20, 2024 Category: Molecular Biology Authors: Chiara Mozzetta Vittorio Sartorelli Christian Steinkuhler Pier Lorenzo Puri Source Type: research